A Blueprint for Translational Integrated Drug Discovery

What does the future of your drug discovery program look like? Many industry leaders are finding themselves in uncharted waters: the science is more sophisticated than ever, producing paradigm-altering treatments. But, historically high R&D costs and low success rates has emphasized the need to identify drugs focused on translationally-relevant targets in the most cost and time efficient way.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

New drugs for the old enemy

Despite the efforts towards malaria eradication, the latest estimates show that the number of cases is rising and malaria continues to have a devastating impact on the most vulnerable populations.
Watch Now

The Future of Real-World Evidence: Pharma’s Next Moves

Throughout the pharma industry, real-world evidence (RWE) is leveraged across organizations for key decision-making within a therapy’s life cycle — from R&D to new US Food and Drug Administration (FDA) drug submissions to commercial strategy operations.
Watch Now

Drug Discovery & Development Virtual Event Series 2023

Labroots and the Drug Discovery planning committee are pleased to announce its 6th Annual Event in the Drug Discovery & Development Virtual Event Series.
Watch Now

See the Impossible: Navigating Pharma Procurement in a Complicated World

go.meetings-incentives

M&IW’s HMCC-certified buyers recently attended Pharma Forum and picked up the latest and greatest tips on sourcing healthcare meetings. In our next See the Impossible Webinar Series, learn how transparency, accountability and creative thinking can alleviate unnecessary back and forth and streamline the hotel procurement process.
Watch Now